NEW YORK, NY / ACCESSWIRE / May 23, 2017 / Amgen's bad day has turned into a winning victory for Radius. Radius' shares rallied after it was revealed that rival Amgen's osteoporosis drug candidate ...
Chris Knight: The seasoned actors take it all very seriously, which helps ground the fantastical premise in a sense of reality You can save this article by registering for free here. Or sign-in if you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback